Novelos Therapeutics to raise $5.9M as it advances cancer-targeted compounds
05 December 2011
Nancy Faigen
Please Login to read the full article.
05 December 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Aveo licences preclinical RON-targeted antibodies to J&J, for $15 million up front
- Keryx, Aeterna Zentaris plummet on perifosine colorectal cancer drug failure
- Oncothryreon snags $47M for early anticancers
- Peregrine holds out for survival data as tepid Phase II PFS in NSCLC vexes market
ANALYSIS
Other Informa Analysis
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
